The global acute kidney injury treatment market stands at USD 2.7 billion in 2026 and is projected to expand significantly to USD 5.7 billion by 2036, reflecting a compound annual growth rate (CAGR) of 7.6%. This growth trajectory underscores the rising clinical urgency surrounding acute kidney injury (AKI), a condition affecting approximately 13.3 million people worldwide each year...